Edesa Biotech, Inc.EDSANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank14
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-7.32M
Near historical average
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-6.96M
Historical baseline
PeriodValueYoY Change
2025$-7.32M-49.7%
2024$-4.89M+26.3%
2023$-6.64M+46.0%
2022$-12.28M+10.1%
2021$-13.67M-172.3%
2020$-5.02M-3.4%
2019$-4.85M+2.9%
2018$-5.00M+0.1%
2017$-5.00M-1.9%
2016$-4.91M-